Rare diseases
Investigational molecules
Locations
J.H. Oortweg 21, 2333 CH Leiden, The Netherlands
Vico Therapeutics B.V. focuses on clinical research in spinocerebellar ataxia type 1, spinocerebellar ataxia type 3, and Huntington’s disease, with attention to disorders marked by progressive motor and neurological impairment.
The sponsor’s research activity is centered on conditions affecting coordination, movement control, and neurological function.
Vico Therapeutics B.V. runs clinical trials in conditions such as Hereditary ataxia, Huntington's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease
DenmarkLong‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
